PanCAN Scientific Summit 2023

5:30 p.m. — 6:30 p.m.

PanCAN Scientific and Medical Advisory Board Reception (invite only)

Strega Restaurant, Wine Room

6:30 p.m. — 8:30 p.m.

General Reception and Poster Session

Terrace Room, Lower Level

Welcome Remarks
Julie Fleshman, JD, MBA, PanCAN President and CEO

Poster Session
2022 Class of Career Development Awards

The role of PP2A in regulating pancreatic cancer macropinocytosis
Brittany Allen-Petersen, PhD, Purdue University
Grant funded by The Rockhammer Charitable Fund

A novel mechanism of MDSC-mediated stromal and T-cell dysregulation
Jashodeep Datta, MD, University of Miami
Grant funded by an anonymous donor

KRAS G12R metabolic reprogramming alters therapeutic sensitivity
G. Aaron Hobbs, PhD, Medical University of South Carolina
Grant funded in memory of Skip Viragh

Immunobiological factors associated with pancreatic cancer disparities
Janielle Maynard, PhD, Johns Hopkins University of School of Medicine
Grant funded by the Chrysalis Fund at the Ventura County Community Foundation

Neuronal checkpoint signaling in pancreas cancer pain
Jami Saloman, PhD, University of Pittsburgh
Grant funded in memory of Skip Viragh

Exploiting the gut microbiome to improve therapy response in PDAC
Rahul Shinde, PhD, The Wistar Institute
Grant funded by an anonymous donor

Fibrosis-mediated transformation in pancreatic cancer risk factors in vitro
Catherine Whittington, PhD, Worcester Polytechnic Institute

2022 Therapeutic Accelerator Award and Therapeutic Accelerator Collaborative Awards

Clinical update and translational studies for the phase 1/2 trial of VS-6766 + Defactinib and GEM + Nab-P in metastatic PDAC
Louis Denis, MD, and Jonathan Pachter, PhD, Verastem Oncology
Grant supported by 1440 Foundation, the Gail V. Coleman-Kenneth M. Bruntel Research Fund, and Lyda Hill Philanthropies

The RAF/MEK clamp avutometinib as the backbone of therapy for pancreatic cancer: Novel combinations with standard of care chemotherapy, FAK inhibitors, KRAS G12D inhibitors and/or autophagy inhibitors
Kirsten Bryant, PhD, and Channing Der, PhD, University of North Carolina at Chapel Hill
Therapeutic Accelerator Collaborative Award funded in memory of Llewellyn Bixby IV through a gift made by his family
David DeNardo, PhD, Washington University in St. Louis
Jonathan Pachter, PhD, Verastem Oncology
Therapeutic Accelerator Award supported by 1440 Foundation, the Gail V. Coleman-Kenneth M. Bruntel Research Fund, and Lyda Hill Philanthropies

7:30 — 8:30 a.m.

Breakfast

Terrace Room, Lower Level

8:30 a.m. — 3:30 p.m.

Scientific Sessions

The Square, Lobby Level

8:30 — 8:35 a.m.

Welcome

Julie Fleshman, JD, MBA
Eileen O’Reilly, MD, Memorial Sloan Kettering Cancer Center
Chair, PanCAN Scientific and Medical Advisory Board

8:35 — 9:05 a.m.

PanCAN State of the Union and Welcome 2023 Class of Grantees

Julie Fleshman, JD, MBA

9:05 — 9:50 a.m.

Early Detection

Session Facilitator: Lynn Matrisian, PhD, MBA, PanCAN Chief Science Officer

9:50 — 10:20 a.m.

Health Data

Session Facilitator: Sudheer Doss, PhD, PanCAN Chief Business Officer

10:20 — 10:35 a.m.

Break

10:35 a.m. — 12:15 p.m.

2021 Career Development Awards

Session Facilitators: Julie Fleshman, JD, MBA, Eileen O’Reilly, MD

12:15 — 1:00 p.m.

Lunch

Terrace Room, Lower Level

1:05 — 3:20 p.m.

Pancreatic Cancer Treatment Approaches

1:05 — 2:25 p.m.

Translational Research Grants

Session Facilitators: Julie Fleshman, JD, MBA, Eileen O’Reilly, MD

2:25 — 3:20 p.m.

Precision Medicine Targeted Grant and Therapeutic Accelerator Award

Session Facilitator: Lynn Matrisian, PhD, MBA

3:20 — 3:30 p.m.

Closing Remarks

Eileen O’Reilly, MD, Julie Fleshman, JD, MBA

3:30 p.m. — 4:30 p.m.

Coffee Social/Networking Hour

Library, Lobby Level

Please check back following the conference for attendee contact information.